Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 30%
9 stocks to trade ex-dividend on Monday. Last chance to buy for eligibility
Sonata Software, Jindal Stainless among 8 stocks that rose above VWAP on August 12
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
Glenmark Life - Alivus Life Sciences Share Price
Loading...
| Open | 1,031.40 |
| High | 1,047.00 |
| Low | 1,009.00 |
| Prev Close | 1,031.40 |
| Volume | 88,586 |
| VWAP(₹) | 1,027.15 |
Key Metrics
| PE Ratio(x) | 22.12 |
| EPS - TTM(₹) | 45.99 |
| MCap(₹ Cr.) | 12,484.74 |
| MCap Rank | 40 |
| PB Ratio(x) | 3.80 |
| Div Yield(%) | - |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 1,148.40 |
| 52W Low(₹) | 819.00 |
| MCap/Sales | 4.69 |
| Beta(1 Month) | - |
| BV/Share(₹) | 271.49 |
Glenmark Life share price insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 10.68% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Glenmark Life Share Price Update
Alivus Life Sciences Ltd. share price moved down by -1.38% from its previous close of Rs 1,031.40. Alivus Life Sciences Ltd. stock last traded price is 1,017.20
Share Price Value Today/Current/Last 1,017.20 Previous Day 1,031.40
Found Insights useful?
Glenmark Life Share Price Returns
| 1 Day | -1.38% |
| 1 Month | -9.66% |
| 3 Months | 7.1% |
| 1 Year | -0.86% |
| 3 Years | 72.28% |
| 5 Years | N.A. |
Glenmark Life Share Recommendations
Mean recosCurrent
STRONG BUY
4 Analysts
Strong
SellSellHoldBuyStrong
Buy
SellSellHoldBuyStrong
Buy
Analyst Trends
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 4 | 4 | 4 | 4 |
Financials
Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Total Income 686.82 602.70 610.83 659.63 652.30 Total Income Growth (%) 13.96 -1.33 -7.40 1.12 26.56 Total Expenses 486.93 427.25 446.60 467.08 466.70 Total Expenses Growth (%) 13.97 -4.33 -4.39 0.08 20.40 EBIT 199.89 175.46 164.23 192.55 185.61 EBIT Growth (%) 13.92 6.83 -14.71 3.74 45.23 Profit after Tax (PAT) 150.26 130.03 121.54 141.87 136.96 PAT Growth (%) 15.56 6.99 -14.33 3.58 43.69 EBIT Margin (%) 29.10 29.11 26.89 29.19 28.45 Net Profit Margin (%) 21.88 21.57 19.90 21.51 21.00 Basic EPS (₹) 12.25 10.60 9.91 11.57 11.18 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 10.68% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Total Assets 3,411.45 2,850.41 2,702.15 2,471.01 1,997.08 Total Assets Growth (%) 19.68 5.49 9.35 23.73 15.73 Total Liabilities 594.08 518.09 563.94 416.70 1,244.33 Total Liabilities Growth (%) 14.67 -8.13 35.33 -66.51 -6.01 Total Equity 2,817.37 2,332.32 2,138.21 2,054.31 752.75 Total Equity Growth (%) 20.80 9.08 4.08 172.91 87.40 Current Ratio (x) 4.97 4.37 3.67 4.60 1.15 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 37.92 34.20 12.83 50.42 17.23 All figures in Rs Cr, unless mentioned otherwise
InsightsZero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Net Cash flow from Operating Activities 391.52 413.52 313.40 597.59 388.11 Net Cash used in Investing Activities -615.65 -116.48 -154.15 -122.23 -68.73 Net Cash flow from Financing Activities -6.23 -279.44 -387.59 -78.80 -213.78 Net Cash Flow -230.35 17.59 -228.33 396.56 105.60 Closing Cash & Cash Equivalent 71.06 301.41 283.82 512.16 115.60 Closing Cash & Cash Equivalent Growth (%) -76.42 6.20 -44.58 343.06 1,056.19 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 570.15 cr for investing activities which is an YoY decrease of 7.39%. (Source: Standalone Financials)
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Return on Equity (%) 17.23 20.18 21.83 20.38 46.70 Return on Capital Employed (%) 22.32 26.24 28.62 28.40 72.00 Return on Assets (%) 14.23 16.51 17.28 16.94 17.60 Interest Coverage Ratio (x) 297.08 443.91 1,227.15 22.56 6.76 Asset Turnover Ratio (x) 0.76 0.82 0.84 0.95 1.01 Price to Earnings (x) 27.25 20.20 10.28 13.44 - Price to Book (x) 4.70 4.07 2.24 2.74 - EV/EBITDA (x) 18.35 13.40 6.69 8.10 - EBITDA Margin (%) 30.04 30.05 31.05 29.70 31.39
Found Financials useful?
Share Price Forecast
Exclusively for ETPrime
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
Technicals
No Data Available
- 41%Positive Movement
since 1st Jan 2005
on basis58%Negative Movement
since 1st Jan 2005
on basisExcludeGlobal Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
MF Ownership as on 30 April 2026
181.22
Amount Invested (in Cr.)
0.596631%
% of AUM
0.00
% Change (MoM basis)
Old Bridge Focused Direct-G
Equity: Flexi Cap120.63
Amount Invested (in Cr.)
4.15%
% of AUM
24.01
% Change (MoM basis)
114.96
Amount Invested (in Cr.)
1.72381769%
% of AUM
-29.77
% Change (MoM basis)
Glenmark Life Top Searches
Corporate Actions
Final
250%
May 14, 2026
Board Meeting
Audited Results & Final Dividend
May 07, 2026
Board Meeting
Quarterly Results
Jan 14, 2026
Announced on Meeting on May 07, 2026 May 14, 2026 Audited Results & Final Dividend Jan 14, 2026 Jan 22, 2026 Quarterly Results Oct 29, 2025 Nov 06, 2025 Quarterly Results Jul 24, 2025 Aug 01, 2025 Quarterly Results May 08, 2025 May 15, 2025 Audited Results & Final Dividend Announced on Ex-Date Dividend% May 15, 2025 Sep 01, 2025 250% Oct 04, 2023 Oct 17, 2023 1125% Mar 14, 2023 Mar 24, 2023 1050% Apr 20, 2022 Sep 15, 2022 525% May 14, 2026 - 250% No Data Available
No Data Available
No Data Available
Announced on Meeting on Aug 11, 2025 Sep 08, 2025 - Jun 23, 2025 Jul 26, 2025 - Oct 25, 2024 Nov 28, 2024 - Apr 25, 2024 Sep 25, 2024 - Sep 01, 2023 Sep 26, 2023 A.G.M.
About Glenmark Life
Alivus Life Sciences Ltd., incorporated in the year 2011, is a Small Cap company (having a market cap of Rs 12,484.74 Crore) operating in Pharmaceuticals sector.
Show More
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Smallcap 500, Nifty Microcap 250
Address
Plot No. 170-172,Chandramouli Industrial Estate,Solapur, Maharashtra - 413213
Executive Leadership
HK
Hiren K Patel
Chairman & Non-Exe.DirectorYR
Yasir Rawjee
Managing Director & CEOVN
Vinod Naik
Executive DirectorKN
Kaushikbhai N Patel
Independent DirectorShow More
Auditors
Walker Chandiok & Co. LLP
FAQs about Glenmark Life share
- 1. What's the Glenmark Life share price today?Glenmark Life share price is Rs 1,017.20 as on 11 Jun, 2026, 03:40 PM IST. Glenmark Life share price is down by 1.38% based on previous share price of Rs. 1035.0.
- 2. What is the market cap of Glenmark Life?Glenmark Life share has a market capitalization of Rs 12,484.74 Cr. Within Pharmaceuticals sector, it's market cap rank is 40.
- 3. What is the PE & PB ratio of Glenmark Life?The PE ratio of Glenmark Life stands at 22.43, while the PB ratio is 4.49.
- 4. What is 52 week high/low of Glenmark Life share price?52 Week high of Glenmark Life share is Rs 1,148.40 while 52 week low is Rs 819.00
- 5. What are the returns for Glenmark Life share?Return Performance of Glenmark Life Shares:
- 1 Week: Glenmark Life share price moved down by 1.80%
Top Gainers
As on 03:59 PM | 11 Jun 2026Top Losers
As on 03:59 PM | 11 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.